Sarborg Ltd - Significant Ownership

Signature - Title
/s/ Mark Taylor - Executive Director
Location
Grand Cayman
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Sarborg Ltd.

Significant Ownership of Sarborg Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CDT CONDUIT PHARMACEUTICALS INC. Common Stock 16.4% $1.69M 1.85M Sarborg Ltd Mar 31, 2025
CDT CDT Equity Inc. Common Stock 4% $167K 124K Sarborg Ltd Jul 8, 2025

Schedules 13D/G Reported by Sarborg Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.